Olema Pharmaceuticals, Inc. OLMA Change in Lease Liabilities
Change in Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Olema Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Olema Pharmaceuticals, Inc.'s change in lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Olema Pharmaceuticals, Inc.'s change in lease liabilities?
- Olema Pharmaceuticals, Inc. (OLMA) reported change in lease liabilities of -$313K in Q1 2026.
- How has Olema Pharmaceuticals, Inc.'s change in lease liabilities changed year-over-year?
- Olema Pharmaceuticals, Inc.'s change in lease liabilities decreased by 1.3% year-over-year, from -$309K to -$313K.
- What is the long-term trend for Olema Pharmaceuticals, Inc.'s change in lease liabilities?
- Over 4 years (2021 to 2025), Olema Pharmaceuticals, Inc.'s change in lease liabilities has grown at a 5.9% compound annual growth rate (CAGR), from -$988K to -$1.24M.
- What does change in lease liabilities mean?
- Cash payments for operating leases reducing the lease liability, partially offset by new lease commencements.